Analysis of the Active Pharmaceutical Ingredients Market

Growth Opportunities Abound in Biological APIs

USD 4,950

* Required Fields

USD 4,950


Be the first to review this product

This study covers the active pharmaceutical ingredients (APIs) market for Singapore, Malaysia, Thailand, Philippines, Indonesia, Vietnam, Australia, and New Zealand. The study is segmented according to the customer base and the ingredient’s mode of synthesis. The study details the revenue forecasts and market trends for generic, innovative, synthetic, and biological APIs. The competitive structure is provided, along with a detailed attractiveness index for contract manufacturing of APIs in each of the countries. Furthermore, drivers and restraints influencing the market are discussed, and the revenue split by country and therapeutic areas is included. The base year is 2011, and forecasts are provided through 2018.

Table of Contents

Analysis of the Active Pharmaceutical Ingredients Market, Active Pharmaceutical IngredientsActive Pharmaceutical Ingredients (API)Analysis of API in APAC region




Related Research

Release Date : 06-Dec-17

Region : Asia Pacific

Release Date : 27-Nov-17

Region : Asia Pacific

Release Date : 24-Nov-17

Region : Asia Pacific

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.